Table 3.
Relevant pharmacogenetics association studies that have focused on catechol-O-methyl transferase (COMT)
| Reference | Gene | Drug | Sample | Outcome measure | Results | p-value |
|---|---|---|---|---|---|---|
| [24] | COMT | Bupropion | 553 smokers | Weight gain after smoking cessation | TC genotype at the C957T locus was associated with increased weight gain at six months of follow-up; however, no polymorphisms, or their interactions with bupropion, consistently and significantly predicted baseline BMI or weight change | Not significant |
| [25] | COMT | Various | 346 MDD patients | HAMD | There was a small effect with citalopram treatment (Val(108/158)Met) | p = 0.007 (gene per time interaction) |
| [26] | COMT | Mirtazapine and paroxetine | 102 MDD patients | HAMD | COMT polymorphism Val(108/158)Met influenced mirtazapine but not paroxetine response | p = 0.011 |
Abbreviations: MDD, major depressive disorder; BMI, body mass index; COMT, catechol-O-methyl transferase; HAMD, Hamilton Rating Scale for Depression